Carlsquare Equity Research comments on the news that NOSA achieved positive results in an in vivo study using the drug delivery plugs. The study showed that a significant level of the drug used in the study was absorbed into blood plasma, demonstrating that the delivery technology works and that therapeutically relevant levels can be achieved.